These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 17336978

  • 21. Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity.
    Vicennati V, Ceroni L, Genghini S, Patton L, Pagotto U, Pasquali R.
    Obesity (Silver Spring); 2006 Feb; 14(2):235-43. PubMed ID: 16571848
    [Abstract] [Full Text] [Related]

  • 22. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.
    Lanzone A, Fulghesu AM, Guido M, Cucinelli F, Caruso A, Mancuso S.
    Fertil Steril; 1997 Jan; 67(1):34-9. PubMed ID: 8986680
    [Abstract] [Full Text] [Related]

  • 23. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB, Sunde A, von Düring V, Carlsen SM.
    Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
    [Abstract] [Full Text] [Related]

  • 24. Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study.
    Romualdi D, Costantini B, Campagna G, Lanzone A, Guido M.
    Fertil Steril; 2008 Nov; 90(5):1826-33. PubMed ID: 18166189
    [Abstract] [Full Text] [Related]

  • 25. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 26. Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome.
    Carmina E, Gonzalez F, Chang L, Lobo RA.
    Obstet Gynecol; 1995 Jun; 85(6):971-6. PubMed ID: 7770269
    [Abstract] [Full Text] [Related]

  • 27. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M, Aydemir M, Tuzcu A.
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration.
    Fulghesu AM, Lanzone A, Fortini A, Guido M, Caruso A, Mancuso S.
    J Reprod Med; 1993 May; 38(5):387-92. PubMed ID: 8320677
    [Abstract] [Full Text] [Related]

  • 29. Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.
    Romualdi D, Guido M, Ciampelli M, Giuliani M, Leoni F, Perri C, Lanzone A.
    Hum Reprod; 2003 Jun; 18(6):1210-8. PubMed ID: 12773448
    [Abstract] [Full Text] [Related]

  • 30. Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
    Guido M, Romualdi D, Suriano R, Giuliani M, Costantini B, Apa R, Lanzone A.
    Hum Reprod; 2004 Mar; 19(3):534-9. PubMed ID: 14998947
    [Abstract] [Full Text] [Related]

  • 31. Plasma adrenomedullin levels in patients with polycystic ovary syndrome.
    Ucar B, Noyan V, Caglayan O, Yucel A, Sagsoz N.
    Fertil Steril; 2006 Oct; 86(4):942-8. PubMed ID: 16963041
    [Abstract] [Full Text] [Related]

  • 32. A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome.
    Glintborg D, Hermann AP, Hagen C, Jensen LT, Frystyk J, Bennett P, Flyvbjerg A, Andersen M.
    Fertil Steril; 2009 Mar; 91(3):842-50. PubMed ID: 18402944
    [Abstract] [Full Text] [Related]

  • 33. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA, Lewy V, Danadian K, Saad R.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [Abstract] [Full Text] [Related]

  • 34. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
    Lizcano F, Salvador J.
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442
    [Abstract] [Full Text] [Related]

  • 35. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea.
    Genazzani AD, Bersi C, Luisi S, Fruzzetti F, Malavasi B, Luisi M, Petraglia F, Genazzani AR.
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):247-52. PubMed ID: 11595505
    [Abstract] [Full Text] [Related]

  • 36. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
    Glintborg D, Højlund K, Andersen M, Henriksen JE, Beck-Nielsen H, Handberg A.
    Diabetes Care; 2008 Feb; 31(2):328-34. PubMed ID: 18000176
    [Abstract] [Full Text] [Related]

  • 37. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
    Genazzani AD, Strucchi C, Luisi M, Casarosa E, Lanzoni C, Baraldi E, Ricchieri F, Mehmeti H, Genazzani AR.
    Gynecol Endocrinol; 2006 Jan; 22(1):36-43. PubMed ID: 16522532
    [Abstract] [Full Text] [Related]

  • 38. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 39. Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.
    Azziz R, Ehrmann DA, Legro RS, Fereshetian AG, O'Keefe M, Ghazzi MN, PCOS/Troglitazone Study Group.
    Fertil Steril; 2003 Apr; 79(4):932-7. PubMed ID: 12749433
    [Abstract] [Full Text] [Related]

  • 40. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.